08533ZZ
Destruction Anterior Chamber, Left to No Qualifier with No Device, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 8 Eye |
| Operation | 5 Destruction |
| Body Part | 3 Anterior Chamber, Left |
| Approach | 3 Percutaneous |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
This family covers procedures that permanently eliminate abnormal or diseased eye tissue using energy, heat, cold, or a chemical agent, without physically removing the tissue from the body. Common examples include laser photocoagulation to seal or destroy abnormal retinal blood vessels in diabetic eye disease or age-related macular degeneration, cyclophotocoagulation to reduce fluid-producing tissue inside the eye as a glaucoma treatment, and cryotherapy or laser treatment of retinal tears to prevent detachment.
These treatments are chosen when the goal is to stop a harmful process at its source, such as leaking vessels or overactive tissue, rather than to excise a specimen for examination. Because the destroyed tissue is left in place to be reabsorbed by the body, these procedures are often less invasive than a comparable excision and can frequently be performed in an outpatient or office laser suite.
Anatomy & Axis Detail
Anterior Chamber, Left
In the left eye, the anterior chamber sits between the cornea and the iris and lens, filled with aqueous humor that nourishes surrounding avascular tissue and maintains intraocular pressure. A Destruction procedure applied to this chamber involves eliminating abnormal tissue in place, such as inflammatory membranes, neovascular tissue, or other pathologic material within the chamber space, using a destructive modality rather than excision or drainage. Given the chamber's proximity to the trabecular meshwork and its role in aqueous outflow, precise operative documentation of the tissue destroyed and the energy source applied helps distinguish this procedure from glaucoma-specific angle surgeries, ensuring the correct root operation and body part combination is selected.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Coding & Documentation
Documentation needs to specify the energy source or agent used, such as laser, cryotherapy probe, or a chemical, and the exact eye structure targeted, since destruction codes in this system are organized by precise anatomical site down to structures like the retina, choroid, or ciliary body. Coders should confirm the intent recorded by the surgeon was ablation or eradication of tissue rather than biopsy or removal of a specimen, because any tissue sent to pathology signals an Excision instead. A recurring error is coding panretinal photocoagulation or focal laser treatments to a generic retina code when the note actually distinguishes treatment areas that map to different body part values.